Charles Gluchowski, PhD
The business challenges today are many; skilled and experienced leadership with a global perspective is essential for addressing these challenges and delivering solid value to stakeholders.
Dr. Gluchowski is the President of Life/Science Innovations LLC (LSI), a SF bay area consulting firm that works on strategic and tactical management, fundraising, business development and R&D projects for life science companies. He has over 25 years of executive, business development and drug R&D experience in both established and start-up companies. He has played an active role in the financing and development of several start-up companies, including the completion of 2 successful IPOs and several M&A transactions.
Dr. Gluchowski has also been responsible for the discovery and development of 2 marketed therapeutics, is a co-inventor on over 75 issued US patents and is a co-author on over 45 peer reviewed articles and book chapters. Dr. Gluchowski has held executive and research leadership positions at the following companies: Medicure, Inc. CTI Molecular Imaging (now part of Siemens), Ceretek LLC, Questcor Pharmaceuticals, RiboGene and Synaptic Pharmaceutical Corp (now part of Lundbeck). He began his industrial career in 1984 as a Scientist, Medicinal Chemistry at Allergan where his efforts led to the development of Allergan’s glaucoma treatments AlphaganTM and LumiganTM.
Prior to joining Allergan, he was a Postdoctoral Research Fellow in Organic Chemistry at the University of Texas at Austin. He received his PhD in Organic Chemistry in 1983 from Texas A&M University in College Station, TX and a BS in Chemistry in 1978 from Stevens Institute of Technology, Hoboken, NJ.